| scholarly article | Q13442814 |
| P50 | author | Andrzej Wojnar | Q24643404 |
| Bartosz Pula | Q57028177 | ||
| Maciej Ugorski | Q59549776 | ||
| Karolina Jablonska | Q85546490 | ||
| Piotr Dzięgiel | Q90395586 | ||
| Marzenna Podhorska-Okołów | Q90395589 | ||
| Agata Zemla | Q114369553 | ||
| Aleksandra Ambicka | Q114369554 | ||
| Janusz Ryś | Q121746270 | ||
| P2093 | author name string | Tomasz Owczarek | |
| P2860 | cites work | Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions* | Q22306227 |
| Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 | Q24657145 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins | Q28140285 | ||
| MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells | Q28207731 | ||
| Role of pineal gland in aetiology and treatment of breast cancer | Q28250931 | ||
| Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats | Q28284736 | ||
| Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway | Q33583914 | ||
| Melatonin and mammary pathological growth. | Q33891563 | ||
| A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases | Q34026661 | ||
| Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases | Q34129373 | ||
| The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. | Q34307802 | ||
| Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis | Q34457144 | ||
| Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway | Q34613650 | ||
| Triple-negative breast cancer: clinical features and patterns of recurrence | Q34658655 | ||
| Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways | Q34788161 | ||
| Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives. | Q34994700 | ||
| Melatonin membrane receptors in peripheral tissues: distribution and functions | Q35784330 | ||
| Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone | Q36080730 | ||
| Melatonin-estrogen interactions in breast cancer. | Q36090778 | ||
| Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1G protein-coupled receptor via repression of ERα, Akt1, and Stat5 | Q36174451 | ||
| Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? | Q36790172 | ||
| Melatonin as a selective estrogen enzyme modulator. | Q37347106 | ||
| Melatonin, sleep disturbance and cancer risk | Q37354527 | ||
| Melatonin: pharmacological aspects and clinical trends. | Q37779783 | ||
| Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin | Q37808250 | ||
| Melatonin--a pleiotropic, orchestrating regulator molecule | Q37824733 | ||
| Melatonin as a natural ally against oxidative stress: a physicochemical examination. | Q37900675 | ||
| Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer | Q37902966 | ||
| New perspectives in melatonin uses | Q37981946 | ||
| Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation | Q38002452 | ||
| The melatonin rhythm: both a clock and a calendar | Q38512239 | ||
| Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells | Q39396408 | ||
| Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production | Q39431604 | ||
| Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. | Q39838796 | ||
| Evidence for a cytoplasmic melatonin receptor | Q40167520 | ||
| Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole | Q40408917 | ||
| Melatonin increases the survival time of animals with untreated mammary tumours: neuroendocrine stabilization. | Q42484391 | ||
| Melatonin and human cancer | Q43964576 | ||
| Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue | Q44130302 | ||
| Mechanisms of cancer inhibition by melatonin | Q45051816 | ||
| Coexpression of the melatonin receptor 1 and nestin in human breast cancer specimens. | Q45954691 | ||
| Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines | Q46268446 | ||
| Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity. | Q46634464 | ||
| Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin | Q48165379 | ||
| Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer | Q48942820 | ||
| Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin. | Q54517081 | ||
| Content of melatonin and other antioxidants in grape-related foodstuffs: measurement using a MEPS-HPLC-F method | Q56981023 | ||
| P433 | issue | 3 | |
| P921 | main subject | melatonin | Q180912 |
| P304 | page(s) | 334-345 | |
| P577 | publication date | 2013-01-17 | |
| P1433 | published in | Journal of Pineal Research | Q15056565 |
| P1476 | title | Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma | |
| P478 | volume | 54 |
| Q33768639 | A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes |
| Q89908478 | Depressive Symptoms, Sleep Profiles and Serum Melatonin Levels in a Sample of Breast Cancer Patients |
| Q37458674 | Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer |
| Q38229317 | Expression and putative functions of melatonin receptors in malignant cells and tissues |
| Q34835245 | Expression of the MT1 melatonin receptor in ovarian cancer cells |
| Q44284930 | Genetic Variations of Melatonin Receptor Type 1A are Associated with the Clinicopathologic Development of Urothelial Cell Carcinoma |
| Q28607080 | LINE-1 activity as molecular basis for genomic instability associated with light exposure at night |
| Q38824160 | Melatonergic system-based two-gene index is prognostic in human gliomas |
| Q47169877 | Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors |
| Q41660894 | Melatonin and Hippo Pathway: Is There Existing Cross-Talk? |
| Q37200722 | Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression. |
| Q37007133 | Melatonin receptor genes in vertebrates |
| Q30489143 | Melatonin, an inhibitory agent in breast cancer. |
| Q58587207 | Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers |
| Q35689110 | Melatonin: an inhibitor of breast cancer |
| Q41126075 | Placental melatonin system is present throughout pregnancy and regulates villous trophoblast differentiation |
| Q91994960 | Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC) |
| Q38708671 | Ramelteon, a selective MT1/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells |
| Q28241693 | Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night |
| Q89908114 | Role of Melatonin in the Regulation of Pain |
| Q47103306 | The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells |
| Q29248164 | URINARY MELATONIN IN RELATION TO POSTMENOPAUSAL BREAST CANCER RISK ACCORDING TO MELATONIN 1 RECEPTOR STATUS |
Search more.